Changing therapeutic paradigms for exudative age-related macular degeneration: antiangiogenic agents and photodynamic therapy (Q30642886)

25 June 2017

Changing therapeutic paradigms for exudative age-related macular degeneration: antiangiogenic agents and photodynamic therapy (English)

1 reference

25 June 2017

angiogenesis inhibitor

1 reference

1 reference

Ciulla TA

1

1 reference

25 June 2017

Danis RP

series ordinal

2

1 reference

25 June 2017

Criswell M

series ordinal

3

1 reference

25 June 2017

Pratt LM

series ordinal

4

1 reference

25 June 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

Expert Opinion on Investigational Drugs

25 June 2017

1 reference

25 June 2017

8

1 reference

25 June 2017

12

1 reference

25 June 2017

2173-2182

1 reference

The impact of the macular photocoagulation study results on the treatment of exudative age-related macular degeneration

25 June 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Pathophysiology of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

A hemodynamic model of the pathogenesis of age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Ocular blood flow velocity in age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Sorsby's fundus dystrophy is genetically linked to chromosome 22q13-qter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Racial differences in the cause-specific prevalence of blindness in east Baltimore

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Vascular endothelial growth factor expression in choroidal neovascularization in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Inhibition of Cell Motility by Interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Regression of experimental iris neovascularization with systemic alpha-interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Interferon alpha-2a in the treatment of exudative senile macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Angiostatic steroids. Method of discovery and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Exudative macular degeneration and intravitreal triamcinolone. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Dye enhanced laser photocoagulation in the treatment of a peripapillary subretinal neovascular membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Indocyanine green enhanced diode laser photocoagulation of subretinal neovascular membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Phthalocyanine Photodynamic Therapy of Experimental Iris Neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Phthalocyanine photodynamic therapy: new strategy for closure of choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Photothrombosis of retinal and choroidal vessels in rabbit eyes using chloroaluminum sulfonated phthalocyanine and a diode laser

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Photodynamic activity of lutetium-texaphyrin in a mouse tumor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Systemic application of photosensitizers in the chick chorioallantoic membrane (CAM) model: photodynamic response of CAM vessels and 5-aminolevulinic acid uptake kinetics by transplantable tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

The Prevalence of Blindness and Visual Impairment among Nursing Home Residents in Baltimore

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.12.2173

10.1517/13543784.8.12.2173

21 January 2018

Identifiers

DOI

1 reference

25 June 2017

1 reference